Status:
RECRUITING
ESPBs vs TAPs for Satisfactory Analgesia Following DIEP Surgery
Lead Sponsor:
University of Kansas Medical Center
Conditions:
Pain
Eligibility:
FEMALE
18-70 years
Phase:
NA
Brief Summary
Breast cancer is the second most common cancer diagnosed in American women . For patients who have undergone surgical mastectomy, autologous breast reconstruction is an alternative option to breast im...
Eligibility Criteria
Inclusion
- Adult women with breast cancer, ASA 1-3, undergoing DIEP flap surgery
Exclusion
- Chronic opioid use contraindications to local anesthetics or regional analgesia Inability to communicate intensity of pain on a numeric analog scale
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT06091241
Start Date
November 1 2023
End Date
December 31 2026
Last Update
July 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160